Robert L. Little
2010
In 2010, Robert L. Little earned a total compensation of $623.5K as Vice President and Chief Commercial Officer at Halozyme Therapeutics, a 51% increase compared to previous year.
Compensation breakdown
| Option Awards | $98,168 |
|---|---|
| Salary | $317,970 |
| Other | $207,384 |
| Total | $623,522 |
Little received $318K in salary, accounting for 51% of the total pay in 2010.
Little also received $98.2K in option awards and $207.4K in other compensation.
Rankings
In 2010, Robert L. Little's compensation ranked 6,968th out of 10,439 executives tracked by ExecPay. In other words, Little earned more than 33.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,968 out of 10,439 | 33rd |
Division Manufacturing | 2,542 out of 3,838 | 34th |
Major group Chemicals And Allied Products | 595 out of 921 | 35th |
Industry group Drugs | 394 out of 680 | 42nd |
Industry Biological Products, Except Diagnostic Substances | 73 out of 142 | 49th |
Source: SEC filing on March 24, 2011.
Little's colleagues
We found seven more compensation records of executives who worked with Robert L. Little at Halozyme Therapeutics in 2010.
2010
Jonathan Lim
Halozyme Therapeutics
Chief Executive Officer
2010
Gregory Frost
Halozyme Therapeutics
Chief Executive Officer
2010
Jonathan Leff
Halozyme Therapeutics
Chief Medical Officer
2010
William Fallon
Halozyme Therapeutics
Vice President, Manufacturing & Operations
2010
H Shepard
Halozyme Therapeutics
Chief Scientific Officer
2010
Kurt Gustafson
Halozyme Therapeutics
Chief Financial Officer
2010
Michael LaBarre
Halozyme Therapeutics